Nyheter om regenerative medicine

Nedan listas samtliga nyheter som behandlar regenerative medicine:

Corline’s heparin technology makes front page >

Nyheten uppdaterades 2013-06-25 13:20

Swedish company Corline Systems AB, maker and distributor of a proprietary and unique heparin coating technology for use in Regenerative Medicine, has had a study of its  technology published in the leading scientific journal Tissue Engineering. The editors chose to place it front page. “Obviously, the inherent capability of our technology to promote cells to […]

The Corline Heparin Conjugate may help in vascular repair >

Nyheten uppdaterades 2012-05-08 14:33

Swedish company Corline Systems AB, maker and distributor of a proprietary and unique heparin coating technology for use in Regenerative Medicine, has been the focus of a scientific presentation at the 5th annual meeting of the Scandinavian Society for Biomaterials that was held in Uppsala, Sweden, May 2012.  Researchers…

Corline’s IP portfolio further strengthened by EU patent >

Nyheten uppdaterades 2012-02-20 16:27

Swedish company Corline Systems AB, maker and distributor of a proprietary and unique heparin coating technology for use in Regenerative Medicine, has been granted approval for Patent Application EPO No. 06 748 063.2 – 2112 by the European Patent Office.  “With this newly granted EU patent, Corline has secured IP protection for its core Regenerative Medicine technology […]

Corline’s first Regenerative Medicine patent granted in the US >

Nyheten uppdaterades 2011-09-15 12:06

Swedish company Corline Systems AB, a maker and distributor of a proprietary and unique heparin coating technology for use in Regenerative Medicine, has been granted Patent No. 7981873 by the US Intellectual Property Office. “This is a break-through for Corline in the world’s largest and most influential market for Regenerative Medicine”, comments CEO Henrik Nittmar.

Breakthrough for Corline’s 1.5 MEUR unique Regenerative Medicine Project – receives Funding from the European Commission >

Nyheten uppdaterades 2011-06-07 13:33

Swedish biotech company Corline Systems AB, a maker and distributor of CHS which is a unique and proprietary heparin coating technology for use on medical devices and for Regenerative Medicine, today announced that a consortium led by Corline has received a substantial grant from the European Commission to further develop the CHS technology for use […]